Registration Options

Activity Dates: 04/08/2024 - 04/08/2027

AAPP 2024 registration is closed.

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

Prescribing of psychotropic medications for mental health diagnoses has long been a “trial-and-error” approach guided by broad guideline recommendations, clinical indicators, and, subsequently, patient response and tolerability to treatment. Many patients require several trials before finding an effective medication they can tolerate. This approach oftentimes results in a delay in the control of symptoms or exposes patients to intolerable side effects. Pharmacogenomic testing provides a strategy to improve the likelihood of choosing safe and effective psychotropic medications. Over the past decade, more research has been published on the clinical applicability of pharmacogenomic testing, leading several organizations to publish recommendations on how these tests can be used in comprehensive medication management. This session will focus on the role psychiatric pharmacists can play in the implementation and application of pharmacogenomic testing in the mental health setting.

Consider making this session part of your BPS Continuing Professional Development plan! Please refer to the BPS Psychiatric Pharmacy Content Outline to see how this activity may align.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Assess the impact of pharmacogenomic testing on patient outcomes in psychiatry.
  2. Incorporate health literacy considerations in education to patients about mental health pharmacogenomic testing results.
  3. Apply pharmacogenomic results to psychiatric treatment decisions in comprehensive medication management.

Continuing Education Credit and Disclosures

Activity Dates: 04/08/2024 - 04/08/2027
ACPE Contact Hours: 1
ACPE Number: 0284-0000-24-024-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.